Chang, Qing <br/><br/>
DOPA-based paclitaxel-loaded liposomes with modifications of transferrin and alendronate for bone and myeloma targeting.  [electronic resource] 

 -  Drug delivery  Nov 2016 
 - 3629-3638 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1521-0464 
<br/><br/><label>Standard No.: </label>10.1080/10717544.2016.1214989  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Alendronate--administration & dosage<br/>Animals<br/>Antineoplastic Agents--administration & dosage<br/>Apoptosis--drug effects<br/>Bone and Bones--drug effects<br/>Cell Line, Tumor<br/>Chemistry, Pharmaceutical--methods<br/>Drug Delivery Systems--methods<br/>Humans<br/>Liposomes--chemistry<br/>Mice<br/>Mice, Inbred ICR<br/>Mice, Nude<br/>Multiple Myeloma--drug therapy<br/>Paclitaxel--administration & dosage<br/>Phosphatidic Acids--administration & dosage<br/>Phosphatidylethanolamines--chemistry<br/>Transferrin--administration & dosage<br/>Xenograft Model Antitumor Assays--methods